Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EPS (Basic): 2020-2024

Historic EPS (Basic) for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to -$3.22.

  • Biofrontera's EPS (Basic) rose 36.73% to -$0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.49, marking a year-over-year decrease of 332.81%. This contributed to the annual value of -$3.22 for FY2024, which is 75.27% up from last year.
  • Latest data reveals that Biofrontera reported EPS (Basic) of -$3.22 as of FY2024, which was up 75.27% from -$13.02 recorded in FY2023.
  • Over the past 5 years, Biofrontera's EPS (Basic) peaked at -$0.61 during FY2022, and registered a low of -$479.48 during FY2020.
  • Over the past 3 years, Biofrontera's median EPS (Basic) value was -$3.22 (recorded in 2024), while the average stood at -$5.62.
  • In the last 5 years, Biofrontera's EPS (Basic) spiked by 99.11% in 2021 and then plummeted by 2,034.43% in 2023.
  • Biofrontera's EPS (Basic) (Yearly) stood at -$479.48 in 2020, then surged by 99.11% to -$4.28 in 2021, then spiked by 85.75% to -$0.61 in 2022, then plummeted by 2,034.43% to -$13.02 in 2023, then surged by 75.27% to -$3.22 in 2024.